Long-term Follow-Up Study of Deep Brain Stimulation for Primary Generalized Dystonia

Li Jiaming,Li Nan,Wang Xuelian,Wang Xin,Jing Jiangpeng

DOI: https://doi.org/10.3760/cma.j.issn.1001-2346.2019.10.005

2019-01-01

Abstract:Objective To evaluate the long-term efficacy of deep brain stimulation (DBS) for the treatment of primary generalized dystonia (PGD) and to analyze the factors influencing the clinical outcome.Methods We retrospectively analyzed the data of 21 patients with PGD who underwent DBS from December 2004 to April 2013 at Department of Neurosurgery,Tangdu Hospital,Air Force Medical University.DBS targeting the subthalamic nucleus (STN-DBS) was applied in 11 patients,and DBS targeting the globus pallidus internus (GPi-DBS) was performed in 10 patients.The severity of dystonia was assessed using the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS).Multiple linear regression analysis was used to explore the factors affecting clinical outcomes.Results The follow-up period ranged from 5 years to 11 years,and the median time was 6.5 years.The average improvement rate of BFMDRS movement scores was 65.7％ ± 13.9％ and the median improvement rate of disability scores was 54.5 ％ [IQR (interquartile range):17.0％] in the 21 patients with PGD at the last follow-up.The mean/median improvement rates of movement score and disability score in STN-DBS group were 64.4％ ± 15.8％ and 57.1％ (IQR:20.2％) respectively,and those in GPi-DBS group were 67.1％ ± 12.2％ and 52.8％ (IQR:18.0％) respectively.There was no significant difference in the average improvement rate of BFMDRS movement score or disability score between STN-DBS and GPi-DBS group (both P ＞ 0.05).Multiple linear regression analysis showed that only the course of disease had a significant effect on clinical outcome,which was negatively correlated with the results (t =-7.082,P ＜ 0.001).The remaining variables including gender,age of onset,age of surgery,DBS target and preoperative movement score had no effect on clinical efficacy (all P ＞ 0.05).Conclusions DBS treatment of PGD is effective.Both GPi and STN can be used as alternative therapeutic targets and their efficacies seem similar.Patients with shorter disease duration may achieve better clinical outcomes.